Renin-inhibitors
Uniretic
The FDA lists this product in 3 strengths and forms.
Composition
- Active ingredients
- HYDROCHLOROTHIAZIDE 12.5MG; MOEXIPRIL HYDROCHLORIDE 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- HYDROCHLOROTHIAZIDE 25MG; MOEXIPRIL HYDROCHLORIDE 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020729-002 · Discontinued
- HYDROCHLOROTHIAZIDE 12.5MG; MOEXIPRIL HYDROCHLORIDE 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020729-003 · Discontinued
- HYDROCHLOROTHIAZIDE 12.5MG; MOEXIPRIL HYDROCHLORIDE 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020729.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.